AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
ROSUVASTATIN in Zimbabwe
8 products registered with MCAZ — 8 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CP-ROSUVASTATIN TABLET, COATED; ORAL | 2026/12.8/7333 | COSPHARM INVESTMENTS PVT LTD | active | 10 Mar 2031 |
| CP-ROSUVASTATIN TABLET, COATED; ORAL | 2026/12.8/7334 | COSPHARM INVESTMENTS PVT LTD | active | 10 Mar 2031 |
| CP-ROSUVASTATIN TABLET, COATED; ORAL | 2026/12.8/7335 | COSPHARM INVESTMENTS PVT LTD | active | 10 Mar 2031 |
| CP-ROSUVASTATIN TABLET, COATED; ORAL | 2026/12.8/7336 | COSPHARM INVESTMENTS PVT LTD | active | 10 Mar 2031 |
| STATINOR 10 TABLET, COATED; ORAL | 2018/12.8/5533 | HETERO LABS LTD | active | 27 Feb 2030 |
| STATINOR 20 TABLET, COATED; ORAL | 2018/12.8/5534 | HETERO LABS LTD | active | 27 Feb 2030 |
| ROVAS 20 TABLET, COATED; ORAL | 2015/12.8/4985 | INTAS PHARMACEUTICALS LTD | active | 31 Dec 2027 |
| ROVAS 10 TABLET, COATED; ORAL | 2015/12.8/4986 | INTAS PHARMACEUTICALS LTD | active | 31 Dec 2027 |
ROSUVASTATIN — MCAZ Registration Details
MCAZ (Zimbabwe) has 8 registered products containing ROSUVASTATIN, of which 8 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track ROSUVASTATIN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.